Schedule - APHIA 2025 - Asia-Pacific Histocompatibility and Immunogenetics Association

Schedule

Pre-congress Workshop at the Thai Red Cross Society (Premium Sponsor)

Time	Subject	Room
8.30-10.00	MagSort workshop • (Pre-Registration required)	HLA Lab at 3^rd floor, National Blood Centre Thai Red Cross Society
10.00-10.20	Break	Chumphot 1-2 Lecture Hall at 9^th floor, National Blood Centre Thai Red Cross Society (120 seats)
10.20-10.30	Welcome
10.30-12.30	Pre-Transplant Session: • Investigating complex antibody patterns using Single Antigen with MagSort • Case Study Presentations
12.30-13.00	Understanding Epitopes and making better decisions with HLA MatchMaker
13.00-13.45	Lunch
13.45-15.45	Post-Transplant Session: • Non-invasive biomarker monitoring using Cell Free DNA • Case Study Presentations
15.45-16.00	Break
16.00-17.30	Cell Free DNA workshop • (Pre-registration required)	HLA Lab at 3^rd floor, National Blood Centre Thai Red Cross Society

Time	Subject	Room
7.00-8.30	Registration Open
8.15-8.30	Opening Ceremony
	Program supported by Thailand Hub of Talents in Cancer Immunotherapy, (TTCI)
8.30-10.00	Plenary Session 1: Cellular Immunotherapy I • Role of HSCT vs CAR T cells in Hematologic Malignancy A/Prof. Kitsada Wudhikarn, Division of Hematology, Faculty of Medicine, Chulalongkorn University, Thailand • Challenges in delivering cellular therapies for transplant recipients and cancer patients Prof. Rajiv Khanna, Co-Director, Queensland Immunology Research Centre; Distinguished Scientist, Tumour Immunology Laboratory, QIMR Berghofer Medical Research Institute, Australia • mRNA-based T cell engineering for treatment of virus-related cancer and virus infection Prof. Antonio Bertoletti, Duke-NUS Graduate Medical School, Singapore
10.00-10.30	Coffee Break
10.30-12.00	Plenary Session 2: Cellular Immunotherapy II • Clinical Application of Mesenchymal Stem Cells: Current Trends and Future Directions Prof. Jacques Galipeau, Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health, University of Wisconsin in Madison, USA • T cell receptors and MHC diversity in risk, prognosis, and therapy for gliomas A/Prof. Gary Kohanbash, Director, PNIO Laboratory, Faculty of the Department of Neurological Surgery at UPMC Children’s Hospital of Pittsburgh, USA • Novel pans solid tumor CAR T cells and first in human trial in DIPG Assoc. Prof. Supannikar Tawinwung, Cellular Immunotherapy Research Unit, Chulalongkorn University; Facility Director, Cell and Gene Therapy Manufacturing Center, King Chulalongkorn Memorial Hospital, Thailand
12.00-13.00	Lunch
13.00-13.30	Sponsor Session I
13.30-14.00	Sponsor Session II
14.00-14.30	Short Oral Session
14.30-16.30	Coffee Break with Poster Session
14.00-16.30	Concurrent Workshop (Major Sponsor)	1201
18.00-21.00	Welcome Reception (Mandarin Hotel, Manage by Center Point)

Time	Subject	Room
8.30-10.00	Plenary Session 3: Haematopoietic Stem Cell Transplantation • HSCT: An update Dr. Dianne De Santis, PhD, FFSc (RCPA) Clinical Scientist Department of Clinical Immunology, PathWest, Fiona Stanley Hospital Adjunct Senior Teaching Fellow, University of Western Australia • Saving Lives Across Borders: The Asia-Pacific Unrelated Stem Cell Donor Registry Experience Pawinee Kupatawintu, National Blood Center, the Thai Red Cross Society, Thailand Prof. Ram Mohan Jaiswal, Mahatma Gandhi Medical College & Hospital, India Garth Healey, Australian Bone Marrow Donor Registry, Australia
10.00-10.30	Coffee Break
10.30-12.00	Plenary Session 4: HLA Genomics and Clinical Relevance • HLA in Diseases Susceptibility and Personalized Medicine Prof. Katsushi Tokunaga, Director, Genome Medical Science Project, Research Institute, National Center for Global Health and Medicine (NCGM); Director, Central Biobank, National Center Biobank Network (NCBN), Japan • Clinical implementation of HLA long-read sequencing A/Prof. Pajaree Chariyavilaskul, Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Thailand • HLA Typing and Beyond with Nanopore Sequencing Dr. Thidathip Wongsurawat, Head Division of Medical Bioinformatics, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand • Beyond Traditional HLA Typing: NGS and HLA Imputation for Comprehensive Analysis of HLA Alleles in Thai SLE Patients Dr. Charles Khor Seik-Soon, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore
12.00-13.00	Lunch
13.00-13.30	Sponsor Session III (Thermo Fisher) • Improving The Efficiency And Reliability Of Post-Transplantation Monitoring And Prognosis with Donor-Derived Cell-Free DNA (dd-cfDNA)
13.30-14.00	Sponsor Session IV (TBG) • HLA typing using Nanopore with Automation
14.00-14.30	Short Oral Session
14.30-16.30	Coffee Break with Poster Session
14.00-16.30	Concurrent Workshop (Major Sponsor)	1201
18.00-21.00	Gala Dinner (Councilor and Speaker Plus Guest with ticket)

Time	Subject	Room
8.30-10.00	Plenary Session 5: Solid Organ Transplantation I • Implementation of Virtual Crossmatching in Australia: the laboratory experience Fiona Hudson, Senior Scientist at VTIS, Melbourne, Australia • Determining compatibility in Solid Organ Transplantation – Challenges and Opportunities Rhonda Holdsworth HLA Specialist and Clinical Scientist Specialist Advisor, Transplantation and Immunogenetics Services Pathology and Clinical Governance Division, Australian Red Cross Lifeblood, Australia • Non-HLA antibodies in solid organ transplant Dr. Lucy Sullivan, Scientific Director at Australian Red Cross LifeBlood, Australia
10.00-10.30	Coffee Break
10.30-12.00	Interactive Session • Case Studies for Complex Patients Assoc. Prof. Duangtawan Thammanichanond, Histocompatibility and Immunogenetics Laboratory, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand Assoc. Prof. Natavudh Townamchai, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Thailand Dr. Mary Diviney, Senior Clinical Scientist / Manager, Victorian Transplantation and Immunogenetics Service (VTIS), Australian Red Cross Lifeblood, Australia Asst. Prof. Peenida Skulratanasak Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
12.00-13.00	Lunch
13.00-13.30	Special Lecture by the ASHI President • Expanding Access to Transplantation: Utilization of A2 Kidneys for O and B Recipients Dr. Cathi Murphey, Director, Histocompatibility and Immunogenetics Laboratory, Southwest Immunodiagnostics, Inc.. San Antonio, USA
13.30-14.30	Short Oral and Poster Session
14.30-15.00	Coffee Break
15.00-16.00	Plenary Session 6: Solid Organ Transplantation II • Management of Highly sensitized kidney transplant recipients Prof. Jaeseok Yang, Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital; Laboratory of Transplantation Immunology, Yonsei University Severance Hospital, Korea Prof. Yingyos Avihingsanon, Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Thailand
16.00-16.15	Concluding Remark and Closing